| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $474K | -44.3% |
| Cost of Revenue | $279K | -78.2% |
| R&D Expense | $10.8M | -13.5% |
| SG&A Expense | $7.3M | -10.0% |
| Operating Income | -$22.1M | +17.2% |
| Net Income | -$19.4M | +26.3% |
| EPS (Basic) | -$4.15 | -1120.6% |
| EPS (Diluted) | -$4.15 | -1120.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.9M | -47.0% |
| Accounts Receivable | $102K | -29.2% |
| Inventory | $430K | +306.0% |
| Current Assets | $15.0M | -45.2% |
| Total Assets | $16.7M | -44.0% |
| Current Liabilities | $4.6M | +20.2% |
| Total Liabilities | $5.2M | +1.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.2M | +18.6% |
| Capital Expenditures | $187K | +13.4% |
| Investing Cash Flow | -$187K | -13.4% |
| Financing Cash Flow | $7.1M | +596.2% |
| Free Cash Flow | -$19.4M | +18.3% |
| Stockholders' Equity |
| $11.5M |
| -53.3% |